These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment. Calcetas AT; Thomas KR; Edmonds EC; Holmqvist SL; Edwards L; Bordyug M; Delano-Wood L; Brickman AM; Bondi MW; Bangen KJ; For The Alzheimer's Disease Neuroimaging Initiative Neurobiol Aging; 2022 Oct; 118():1-8. PubMed ID: 35809348 [TBL] [Abstract][Full Text] [Related]
10. Altered functional connectivity pattern of hippocampal subfields in individuals with objectively-defined subtle cognitive decline and its association with cognition and cerebrospinal fluid biomarkers. Qiu T; Zeng Q; Zhang Y; Luo X; Xu X; Li X; Shen Z; Li K; Wang C; Huang P; Zhang M; Dai S; Xie F; Eur J Neurosci; 2022 Dec; 56(12):6227-6238. PubMed ID: 36342704 [TBL] [Abstract][Full Text] [Related]
11. Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease. Besson FL; La Joie R; Doeuvre L; Gaubert M; Mézenge F; Egret S; Landeau B; Barré L; Abbas A; Ibazizene M; de La Sayette V; Desgranges B; Eustache F; Chételat G J Neurosci; 2015 Jul; 35(29):10402-11. PubMed ID: 26203136 [TBL] [Abstract][Full Text] [Related]
12. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]
13. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease. Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA; Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519 [TBL] [Abstract][Full Text] [Related]
14. Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults. Guo T; Landau SM; Jagust WJ; Neurology; 2020 Apr; 94(14):e1512-e1524. PubMed ID: 32188766 [TBL] [Abstract][Full Text] [Related]
16. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals. Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843 [TBL] [Abstract][Full Text] [Related]
17. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment. Thomas KR; Edmonds EC; Eppig J; Salmon DP; Bondi MW; J Alzheimers Dis; 2018; 64(1):195-204. PubMed ID: 29865077 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias. Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593 [TBL] [Abstract][Full Text] [Related]
19. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI. Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942 [TBL] [Abstract][Full Text] [Related]
20. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Jack CR; Lowe VJ; Weigand SD; Wiste HJ; Senjem ML; Knopman DS; Shiung MM; Gunter JL; Boeve BF; Kemp BJ; Weiner M; Petersen RC; Brain; 2009 May; 132(Pt 5):1355-65. PubMed ID: 19339253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]